Structural and functional analysis of domains of the progesterone receptor

Molecular and Cellular Endocrinology

Volumn 348, Issue 2, 2012, Pages 418-429

  Hill, Krista K ^a   Roemer, Sarah C ^b   Churchill, Mair E A ^b   Edwards, Dean P ^c  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Amino terminal domain (NTD); Carboxyl terminal extension (CTE); High mobility group B (HMGB) protein; Intrinsic disorder; Jun dimerization protein 2 (JDP 2); Progesterone receptor

Indexed keywords

CELL NUCLEUS RECEPTOR; DNA; HIGH MOBILITY GROUP B PROTEIN; JUN DIMERIZATION PROTEIN 2; PROGESTERONE RECEPTOR; REGULATOR PROTEIN; STEROID RECEPTOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; DIMERIZATION; DNA BINDING; DNA FLANKING REGION; HORMONE RESPONSIVE ELEMENT; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; THERMODYNAMICS;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; DNA; GENE EXPRESSION REGULATION; HIGH MOBILITY GROUP PROTEINS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, PROGESTERONE; RESPONSE ELEMENTS;

EID: 82655172410     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.07.017     Document Type: Review

References (141)

1. Abdel-Hafiz H., Dudevoir M.L., Horwitz K.B. Mechanisms underlying the control of progesterone receptor transcriptional activity by SUMOylation. J. Biol. Chem. 2009, 284:9099-9108.
2. Abdel-Hafiz H., Takimoto G.S., Tung L., Horwitz K.B. The inhibitory function in human progesterone receptor N termini binds SUMO-1 protein to regulate autoinhibition and transrepression. J. Biol. Chem. 2002, 277:33950-33956.
3. Agresti A., Scaffidi P., Riva A., Caiolfa V.R., Bianchi M.E. GR and HMGB1 interact only within chromatin and influence each other's residence time. Mol. Cell 2005, 18:109-121.
4. Allan G.F., Leng X., Tsai S.Y., Weigel N.L., Edwards D.P., Tsai M.J., O'Malley B.W. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J. Biol. Chem. 1992, 267:19513-19520.
5. Aronheim A., Zandi E., Hennemann H., Elledge S.J., Karin M. Isolation of an AP-1 repressor by a novel method for detecting protein-protein interactions. Mol. Cell. Biol. 1997, 17:3094-3102.
6. Bain D.L., Franden M.A., McManaman J.L., Takimoto G.S., Horwitz K.B. The N-terminal region of the human progesterone A-receptor. Structural analysis and the influence of the DNA binding domain. J. Biol. Chem. 2000, 275:7313-7320.
7. Bain D.L., Franden M.A., McManaman J.L., Takimoto G.S., Horwitz K.B. The N-terminal region of human progesterone B-receptors: biophysical and biochemical comparison to A-receptors. J. Biol. Chem. 2001, 276:23825-23831.
8. Ballare C., Uhrig M., Bechtold T., Sancho E., Di Domenico M., Migliaccio A., Auricchio F., Beato M. Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells. Mol. Cell. Biol. 2003, 23:1994-2008.
9. Beato M., Klug J. Steroid hormone receptors: an update. Hum. Reprod. Update 2000, 6:225-236.
10. Bianchi M.E., Agresti A. HMG proteins: dynamic players in gene regulation and differentiation. Curr. Opin. Genet. Dev. 2005, 15:496-506.
11. Blanco J.C., Minucci S., Lu J., Yang X.J., Walker K.K., Chen H., Evans R.M., Nakatani Y., Ozato K. The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev. 1998, 12:1638-1651.
12. Boonyaratanakornkit V., McGowan E., Sherman L., Mancini M.A., Cheskis B.J., Edwards D.P. The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle. Mol. Endocrinol. 2007, 21:359-375.
13. Boonyaratanakornkit V., Melvin V., Prendergast P., Altmann M., Ronfani L., Bianchi M.E., Taraseviciene L., Nordeen S.K., Allegretto E.A., Edwards D.P. High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Mol. Cell. Biol. 1998, 18:4471-4487.
14. Boonyaratanakornkit V., Scott M.P., Ribon V., Sherman L., Anderson S.M., Maller J.L., Miller W.T., Edwards D.P. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol. Cell 2001, 8:269-280.
15. Bourguet W., Germain P., Gronemeyer H. Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. Trends Pharmacol. Sci. 2000, 21:381-388.
16. Brzozowski A.M., Pike A.C., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., Ohman L., Greene G.L., Gustafsson J.A., Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997, 389:753-758.
17. Calogero S., Grassi F., Aguzzi A., Voigtlander T., Ferrier P., Ferrari S., Bianchi M.E. The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat. Genet. 1999, 22:276-280.
18. Chandra V., Huang P., Hamuro Y., Raghuram S., Wang Y., Burris T.P., Rastinejad F. Structure of the intact PPAR-gamma-RXR-nuclear receptor complex on DNA. Nature 2008, 456:350-356.
19. Choudhry M.A., Ball A., McEwan I.J. The role of the general transcription factor IIF in androgen receptor-dependent transcription. Mol. Endocrinol. 2006, 20:2052-2061.
20. Claessens F., Denayer S., Van Tilborgh N., Kerkhofs S., Helsen C., Haelens A. Diverse roles of androgen receptor (AR) domains in AR-mediated signaling. Nucl. Recept. Signal. 2008, 6:e008.
21. Clemm D.L., Sherman L., Boonyaratanakornkit V., Schrader W.T., Weigel N.L., Edwards D.P. Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody. Mol. Endocrinol. 2000, 14:52-65.
22. Connaghan-Jones K.D., Heneghan A.F., Miura M.T., Bain D.L. Hydrodynamic analysis of the human progesterone receptor A-isoform reveals that self-association occurs in the micromolar range. Biochemistry 2006, 45:12090-12099.
23. Connaghan-Jones K.D., Heneghan A.F., Miura M.T., Bain D.L. Thermodynamic analysis of progesterone receptor-promoter interactions reveals a molecular model for isoform-specific function. Proc. Natl .Acad. Sci. USA 2007, 104:2187-2192.
24. Connaghan-Jones K.D., Heneghan A.F., Miura M.T., Bain D.L. Thermodynamic dissection of progesterone receptor interactions at the mouse mammary tumor virus promoter: monomer binding and strong cooperativity dominate the assembly reaction. J. Mol. Biol. 2008, 377:1144-1160.
25. Copik A.J., Webb M.S., Miller A.L., Wang Y., Kumar R., Thompson E.B. Activation function 1 of glucocorticoid receptor binds TATA-binding protein in vitro and in vivo. Mol. Endocrinol. 2006, 20:1218-1230.
26. Daniel A.R., Gaviglio A.L., Czaplicki L.M., Hillard C.J., Housa D., Lange C.A. The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention. Mol. Endocrinol. 2010, 24:2126-2138.
27. Daniel A.R., Lange C.A. Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells. Proc. Natl. Acad. Sci. USA 2009, 106:14287-14292.
28. Daniel A.R., Qiu M., Faivre E.J., Ostrander J.H., Skildum A., Lange C.A. Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth. Steroids 2007, 72:188-201.
29. Das D., Peterson R.C., Scovell W.M. High mobility group B proteins facilitate strong estrogen receptor binding to classical and half-site estrogen response elements and relax binding selectivity. Mol. Endocrinol. 2004, 18:2616-2632.
30. Das D., Scovell W.M. The binding interaction of HMG-1 with the TATA-binding protein/TATA complex. J. Biol. Chem. 2001, 276:32597-32605.
31. Ding L., Yan J., Zhu J., Zhong H., Lu Q., Wang Z., Huang C., Ye Q. Ligand-independent activation of estrogen receptor alpha by XBP-1. Nucleic Acids Res. 2003, 31:5266-5274.
32. Dintilhac A., Bernues J. HMGB1 interacts with many apparently unrelated proteins by recognizing short amino acid sequences. J. Biol. Chem. 2002, 277:7021-7028.
33. Dong X., Challis J.R., Lye S.J. Intramolecular interactions between the AF3 domain and the C-terminus of the human progesterone receptor are mediated through two LXXLL motifs. J. Mol. Endocrinol. 2004, 32:843-857.
34. Dyson H.J., Wright P.E. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 2005, 6:197-208.
35. Edwards D.P., Wardell S.E., Boonyaratanakornkit V. Progesterone receptor interacting coregulatory proteins and cross talk with cell signaling pathways. J. Steroid Biochem. Mol. Biol. 2002, 83:173-186.
36. Faus H., Haendler B. Post-translational modifications of steroid receptors. Biomed. Pharmacother. 2006, 60:520-528.
37. Fernandez-Valdivia R., Mukherjee A., Mulac-Jericevic B., Conneely O.M., DeMayo F.J., Amato P., Lydon J.P. Revealing progesterone's role in uterine and mammary gland biology: insights from the mouse. Semin. Reprod. Med. 2005, 23:22-37.
38. Ferron F., Longhi S., Canard B., Karlin D. A practical overview of protein disorder prediction methods. Proteins 2006, 65:1-14.
39. Fu M., Rao M., Wang C., Sakamaki T., Wang J., Di Vizio D., Zhang X., Albanese C., Balk S., Chang C., et al. Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Mol. Cell. Biol. 2003, 23:8563-8575.
40. Fu M., Wang C., Reutens A.T., Wang J., Angeletti R.H., Siconolfi-Baez L., Ogryzko V., Avantaggiati M.L., Pestell R.G. p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation. J. Biol. Chem. 2000, 275:20853-20860.
41. Garza A.M., Khan S.H., Kumar R. Site-specific phosphorylation induces functionally active conformation in the intrinsically disordered N-terminal activation function (AF1) domain of the glucocorticoid receptor. Mol. Cell. Biol. 2010, 30:220-230.
42. Gearhart M.D., Holmbeck S.M., Evans R.M., Dyson H.J., Wright P.E. Monomeric complex of human orphan estrogen related receptor-2 with DNA: a pseudo-dimer interface mediates extended half-site recognition. J. Mol. Biol. 2003, 327:819-832.
43. Gewirth D.T., Sigler P.B. The basis for half-site specificity explored through a non-cognate steroid receptor-DNA complex. Nat. Struct. Biol. 1995, 2:386-394.
44. Guermah M., Palhan V.B., Tackett A.J., Chait B.T., Roeder R.G. Synergistic functions of SII and p300 in productive activator-dependent transcription of chromatin templates. Cell 2006, 125:275-286.
45. Haelens A., Tanner T., Denayer S., Callewaert L., Claessens F. The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor. Cancer Res. 2007, 67:4514-4523.
46. Haelens A., Verrijdt G., Callewaert L., Christiaens V., Schauwaers K., Peeters B., Rombauts W., Claessens F. DNA recognition by the androgen receptor: evidence for an alternative DNA-dependent dimerization, and an active role of sequences flanking the response element on transactivation. Biochem. J. 2003, 369:141-151.
47. Hall J.M., McDonnell D.P., Korach K.S. Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements. Mol. Endocrinol. 2002, 16:469-486.
48. 2-terminal conserved motif interacts with the COOH terminus of the Hsp70-interacting protein (CHIP). J. Biol. Chem. 2004, 279:30643-30653.
49. Heneghan A.F., Berton N., Miura M.T., Bain D.L. Self-association energetics of an intact, full-length nuclear receptor: the B-isoform of human progesterone receptor dimerizes in the micromolar range. Biochemistry 2005, 44:9528-9537.
50. Heneghan A.F., Connaghan-Jones K.D., Miura M.T., Bain D.L. Cooperative DNA binding by the B-isoform of human progesterone receptor: thermodynamic analysis reveals strongly favorable and unfavorable contributions to assembly. Biochemistry 2006, 45:3285-3296.
51. Heneghan A.F., Connaghan-Jones K.D., Miura M.T., Bain D.L. Coactivator assembly at the promoter: efficient recruitment of SRC2 is coupled to cooperative DNA binding by the progesterone receptor. Biochemistry 2007, 46:11023-11032.
52. Hill K.K., Roemer S.C., Jones D.N., Churchill M.E., Edwards D.P. A progesterone receptor co-activator (JDP2) mediates activity through interaction with residues in the carboxyl-terminal extension of the DNA binding domain. J. Biol. Chem. 2009, 284:24415-24424.
53. Hilser V.J., Thompson E.B. Intrinsic disorder as a mechanism to optimize allosteric coupling in proteins. Proc. Natl. Acad. Sci. USA 2007, 104:8311-8315.
54. Hock R., Furusawa T., Ueda T., Bustin M. HMG chromosomal proteins in development and disease. Trends Cell Biol. 2007, 17:72-79.
55. Hong C.Y., Gong E.Y., Kim K., Suh J.H., Ko H.M., Lee H.J., Choi H.S., Lee K. Modulation of the expression and transactivation of androgen receptor by the basic helix-loop-helix transcription factor Pod-1 through recruitment of histone deacetylase 1. Mol. Endocrinol. 2005, 19:2245-2257.
56. Hsieh J.C., Jurutka P.W., Selznick S.H., Reeder M.C., Haussler C.A., Whitfield G.K., Haussler M.R. The T-box near the zinc fingers of the human vitamin D receptor is required for heterodimeric DNA binding and transactivation. Biochem. Biophys. Res. Commun. 1995, 215:1-7.
57. Hsieh J.C., Whitfield G.K., Oza A.K., Dang H.T., Price J.N., Galligan M.A., Jurutka P.W., Thompson P.D., Haussler C.A., Haussler M.R. Characterization of unique DNA-binding and transcriptional-activation functions in the carboxyl-terminal extension of the zinc finger region in the human vitamin D receptor. Biochemistry 1999, 38:16347-16358.
58. Iakoucheva L.M., Radivojac P., Brown C.J., O'Connor T.R., Sikes J.G., Obradovic Z., Dunker A.K. The importance of intrinsic disorder for protein phosphorylation. Nucleic Acids Res. 2004, 32:1037-1049.
59. Jeong B.C., Hong C.Y., Chattopadhyay S., Park J.H., Gong E.Y., Kim H.J., Chun S.Y., Lee K. Androgen receptor corepressor-19kDa (ARR19), a leucine-rich protein that represses the transcriptional activity of androgen receptor through recruitment of histone deacetylase. Mol. Endocrinol. 2004, 18:13-25.
60. Jin C., Kato K., Chimura T., Yamasaki T., Nakade K., Murata T., Li H., Pan J., Zhao M., Sun K., et al. Regulation of histone acetylation and nucleosome assembly by transcription factor JDP2. Nat. Struct. Mol. Biol. 2006, 13:331-338.
61. Jin C., Li H., Murata T., Sun K., Horikoshi M., Chiu R., Yokoyama K.K. JDP2, a repressor of AP-1, recruits a histone deacetylase 3 complex to inhibit the retinoic acid-induced differentiation of F9 cells. Mol. Cell. Biol. 2002, 22:4815-4826.
62. Kastner P., Krust A., Turcotte B., Stropp U., Tora L., Gronemeyer H., Chambon P. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 1990, 9:1603-1614.
63. Khorasanizadeh S., Rastinejad F. Nuclear-receptor interactions on DNA-response elements. Trends Biochem. Sci. 2001, 26:384-390.
64. Kim M.Y., Woo E.M., Chong Y.T., Homenko D.R., Kraus W.L. Acetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor. Mol. Endocrinol. 2006, 20:1479-1493.
65. Ko L., Cardona G.R., Henrion-Caude A., Chin W.W. Identification and characterization of a tissue-specific coactivator, GT198, that interacts with the DNA-binding domains of nuclear receptors. Mol. Cell. Biol. 2002, 22:357-369.
66. Kumar R., Baskakov I.V., Srinivasan G., Bolen D.W., Lee J.C., Thompson E.B. Interdomain signaling in a two-domain fragment of the human glucocorticoid receptor. J. Biol. Chem. 1999, 274:24737-24741.
67. Kumar R., Betney R., Li J., Thompson E.B., McEwan I.J. Induced alpha-helix structure in AF1 of the androgen receptor upon binding transcription factor TFIIF. Biochemistry 2004, 43:3008-3013.
68. Kumar R., Thompson E.B. Transactivation functions of the N-terminal domains of nuclear hormone receptors: protein folding and coactivator interactions. Mol. Endocrinol. 2003, 17:1-10.
69. Kumar R., Volk D.E., Li J., Lee J.C., Gorenstein D.G., Thompson E.B. TATA box binding protein induces structure in the recombinant glucocorticoid receptor AF1 domain. Proc. Natl. Acad. Sci. USA 2004, 101:16425-16430.
70. Lavery D.N., McEwan I.J. The human androgen receptor AF1 transactivation domain: interactions with transcription factor IIF and molten-globule-like structural characteristics. Biochem. Soc. Trans. 2006, 34:1054-1057.
71. Le Romancer M., Treilleux I., Bouchekioua-Bouzaghou K., Sentis S., Corbo L. Methylation, a key step for nongenomic estrogen signaling in breast tumors. Steroids 2010, 75:560-564.
72. Lee M.S., Kliewer S.A., Provencal J., Wright P.E., Evans R.M. Structure of the retinoid X receptor alpha DNA binding domain: a helix required for homodimeric DNA binding. Science 1993, 260:1117-1121.
73. Lefstin J.A., Yamamoto K.R. Allosteric effects of DNA on transcriptional regulators. Nature 1998, 392:885-888.
74. Leong H., Sloan J.R., Nash P.D., Greene G.L. Recruitment of histone deacetylase 4 to the N-terminal region of estrogen receptor alpha. Mol. Endocrinol. 2005, 19:2930-2942.
75. Li X., O'Malley B.W. Unfolding the action of progesterone receptors. J. Biol. Chem. 2003, 278:39261-39264.
76. Liao G., Chen L.Y., Zhang A., Godavarthy A., Xia F., Ghosh J.C., Li H., Chen J.D. Regulation of androgen receptor activity by the nuclear receptor corepressor SMRT. J. Biol. Chem. 2003, 278:5052-5061.
77. Link K.A., Burd C.J., Williams E., Marshall T., Rosson G., Henry E., Weissman B., Knudsen K.E. BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF. Mol. Cell. Biol. 2005, 25:2200-2215.
78. Liu J., Perumal N.B., Oldfield C.J., Su E.W., Uversky V.N., Dunker A.K. Intrinsic disorder in transcription factors. Biochemistry 2006, 45:6873-6888.
79. Lonard D.M., O'Malley B.W. Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation. Mol. Cell 2007, 27:691-700.
80. Luisi B.F., Xu W.X., Otwinowski Z., Freedman L.P., Yamamoto K.R., Sigler P.B. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 1991, 352:497-505.
81. Ma H., Hong H., Huang S.M., Irvine R.A., Webb P., Kushner P.J., Coetzee G.A., Stallcup M.R. Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins. Mol. Cell. Biol. 1999, 19:6164-6173.
82. Madauss K.P., Grygielko E.T., Deng S.J., Sulpizio A.C., Stanley T.B., Wu C., Short S.A., Thompson S.K., Stewart E.L., Laping N.J., et al. A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulator. Mol. Endocrinol. 2007, 21:1066-1081.
83. Man J.H., Li H.Y., Zhang P.J., Zhou T., He K., Pan X., Liang B., Li A.L., Zhao J., Gong W.L., et al. PIAS3 induction of PRB sumoylation represses PRB transactivation by destabilizing its retention in the nucleus. Nucleic Acids Res. 2006, 34:5552-5566.
84. Martini P.G., Katzenellenbogen B.S. Modulation of estrogen receptor activity by selective coregulators. J. Steroid Biochem. Mol. Biol. 2003, 85:117-122.
85. McEwan I.J., Lavery D., Fischer K., Watt K. Natural disordered sequences in the amino terminal domain of nuclear receptors: lessons from the androgen and glucocorticoid receptors. Nucl. Recept. Signal. 2007, 5:e001.
86. Meijsing S.H., Pufall M.A., So A.Y., Bates D.L., Chen L., Yamamoto K.R. DNA binding site sequence directs glucocorticoid receptor structure and activity. Science 2009, 324:407-410.
87. Melvin V.S., Harrell C., Adelman J.S., Kraus W.L., Churchill M., Edwards D.P. The role of the C-terminal extension (CTE) of the estrogen receptor alpha and beta DNA binding domain in DNA binding and interaction with HMGB. J. Biol. Chem. 2004, 279:14763-14771.
88. Melvin V.S., Roemer S.C., Churchill M.E., Edwards D.P. The C-terminal extension (CTE) of the nuclear hormone receptor DNA binding domain determines interactions and functional response to the HMGB-1/-2 co-regulatory proteins. J. Biol. Chem. 2002, 277:25115-25124.
89. Metivier R., Penot G., Flouriot G., Pakdel F. Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains. Mol. Endocrinol. 2001, 15:1953-1970.
90. Meyer M.E., Pornon A., Ji J.W., Bocquel M.T., Chambon P., Gronemeyer H. Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor. EMBO J. 1990, 9:3923-3932.
91. Meyer M.E., Quirin-Stricker C., Lerouge T., Bocquel M.T., Gronemeyer H. A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms. J. Biol. Chem. 1992, 267:10882-10887.
92. Mote P.A., Balleine R.L., McGowan E.M., Clarke C.L. Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle. J. Clin. Endocrinol. Metab. 1999, 84:2963-2971.
93. Mote P.A., Bartow S., Tran N., Clarke C.L. Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis. Breast Cancer Res. Treat. 2002, 72:163-172.
94. Moure, M.C., Callaway, C., Kumar, R., Edwards, D.P., 2009. Protein induced folding of the intrinsically disordered amino-terminal domain of progesterone receptor controls transcriptional activity of AF1. In Annual Endocrine Society Meetings (Washington, DC).
95. Narayanan R., Edwards D.P., Weigel N.L. Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity. Mol. Cell. Biol. 2005, 25:2885-2898.
96. Nettles K.W., Bruning J.B., Gil G., O'Neill E.E., Nowak J., Guo Y., Kim Y., DeSombre E.R., Dilis R., Hanson R.N., et al. Structural plasticity in the oestrogen receptor ligand-binding domain. EMBO Rep. 2007, 8:563-568.
97. Onate S.A., Boonyaratanakornkit V., Spencer T.E., Tsai S.Y., Tsai M.J., Edwards D.P., O'Malley B.W. The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors. J. Biol. Chem. 1998, 273:12101-12108.
98. Petz L.N., Nardulli A.M., Kim J., Horwitz K.B., Freedman L.P., Shapiro D.J. DNA bending is induced by binding of the glucocorticoid receptor DNA binding domain and progesterone receptors to their response element. J. Steroid Biochem. Mol. Biol. 1997, 60:31-41.
99. Poukka H., Karvonen U., Janne O.A., Palvimo J.J. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc. Natl. Acad. Sci. USA 2000, 97:14145-14150.
100. Poukka H., Karvonen U., Yoshikawa N., Tanaka H., Palvimo J.J., Janne O.A. The RING finger protein SNURF modulates nuclear trafficking of the androgen receptor. J. Cell Sci. 2000, 113(Pt 17):2991-3001.
101. Prendergast P., Pan Z., Edwards D.P. Progesterone receptor-induced bending of its target DNA: distinct effects of the A and B receptor forms. Mol. Endocrinol. 1996, 10:393-407.
102. Proietti C., Salatino M., Rosemblit C., Carnevale R., Pecci A., Kornblihtt A.R., Molinolo A.A., Frahm I., Charreau E.H., Schillaci R., Elizalde P.V. Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells. Mol. Cell. Biol. 2005, 25:4826-4840.
103. Quack M., Szafranski K., Rouvinen J., Carlberg C. The role of the T-box for the function of the vitamin D receptor on different types of response elements. Nucleic Acids Res. 1998, 26:5372-5378.
104. Raaijmakers H.C., Versteegh J.E., Uitdehaag J.C. The X-ray structure of RU486 bound to the progesterone receptor in a destabilized agonistic conformation. J. Biol. Chem. 2009, 284:19572-19579.
105. Rastinejad F., Perlmann T., Evans R.M., Sigler P.B. Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature 1995, 375:203-211.
106. Reid J., Kelly S.M., Watt K., Price N.C., McEwan I.J. Conformational analysis of the androgen receptor amino-terminal domain involved in transactivation. Influence of structure-stabilizing solutes and protein-protein interactions. J. Biol. Chem. 2002, 277:20079-20086.
107. Richer J.K., Jacobsen B.M., Manning N.G., Abel M.G., Wolf D.M., Horwitz K.B. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J. Biol. Chem. 2002, 277:5209-5218.
108. Roemer S.C., Adelman J., Churchill M.E., Edwards D.P. Mechanism of high-mobility group protein B enhancement of progesterone receptor sequence-specific DNA binding. Nucleic Acids Res. 2008, 36:3655-3666.
109. Roemer S.C., Donham D.C., Sherman L., Pon V.H., Edwards D.P., Churchill M.E. Structure of the progesterone receptor-deoxyribonucleic acid complex: novel interactions required for binding to half-site response elements. Mol. Endocrinol. 2006, 20:3042-3052.
110. Saitoh M., Ohmichi M., Takahashi K., Kawagoe J., Ohta T., Doshida M., Takahashi T., Igarashi H., Mori-Abe A., Du B., et al. Medroxyprogesterone acetate induces cell proliferation through up-regulation of cyclin D1 expression via phosphatidylinositol 3-kinase/Akt/nuclear factor-kappaB cascade in human breast cancer cells. Endocrinology 2005, 146:4917-4925.
111. Schultz-Norton J.R., Ziegler Y.S., Likhite V.S., Yates J.R., Nardulli A.M. Isolation of novel coregulatory protein networks associated with DNA-bound estrogen receptor alpha. BMC Mol. Biol. 2008, 9:97.
112. Schultz J.R., Loven M.A., Melvin V.M., Edwards D.P., Nardulli A.M. Differential modulation of DNA conformation by estrogen receptors alpha and beta. J. Biol. Chem. 2002, 277:8702-8707.
113. Sem D.S., Casimiro D.R., Kliewer S.A., Provencal J., Evans R.M., Wright P.E. NMR spectroscopic studies of the DNA-binding domain of the monomer-binding nuclear orphan receptor, human estrogen related receptor-2. The carboxyl-terminal extension to the zinc-finger region is unstructured in the free form of the protein. J. Biol. Chem. 1997, 272:18038-18043.
114. Shaffer P.L., Gewirth D.T. Structural basis of VDR-DNA interactions on direct repeat response elements. EMBO J. 2002, 21:2242-2252.
115. Shaffer P.L., Jivan A., Dollins D.E., Claessens F., Gewirth D.T. Structural basis of androgen receptor binding to selective androgen response elements. Proc. Natl. Acad. Sci. USA 2004, 101:4758-4763.
116. Shiau A.K., Barstad D., Loria P.M., Cheng L., Kushner P.J., Agard D.A., Greene G.L. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 1998, 95:927-937.
117. Skildum A., Faivre E., Lange C.A. Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases. Mol. Endocrinol. 2005, 19:327-339.
118. Takimoto G.S., Tung L., Abdel-Hafiz H., Abel M.G., Sartorius C.A., Richer J.K., Jacobsen B.M., Bain D.L., Horwitz K.B. Functional properties of the N-terminal region of progesterone receptors and their mechanistic relationship to structure. J. Steroid Biochem. Mol. Biol. 2003, 85:209-219.
119. Tanner T.M., Denayer S., Geverts B., Van Tilborgh N., Kerkhofs S., Helsen C., Spans L., Dubois V., Houtsmuller A.B., Claessens F., Haelens A. A 629RKLKK633 motif in the hinge region controls the androgen receptor at multiple levels. Cell. Mol. Life Sci. 2010, 67:1919-1927.
120. Tetel M.J., Giangrande P.H., Leonhardt S.A., McDonnell D.P., Edwards D.P. Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo. Mol. Endocrinol. 1999, 13:910-924.
121. Tung L., Abdel-Hafiz H., Shen T., Harvell D.M., Nitao L.K., Richer J.K., Sartorius C.A., Takimoto G.S., Horwitz K.B. Progesterone receptors (PR)-B and -A regulate transcription by different mechanisms: AF-3 exerts regulatory control over coactivator binding to PR-B. Mol. Endocrinol. 2006, 20:2656-2670.
122. Tung L., Mohamed M.K., Hoeffler J.P., Takimoto G.S., Horwitz K.B. Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. Mol. Endocrinol. 1993, 7:1256-1265.
123. Tung L., Shen T., Abel M.G., Powell R.L., Takimoto G.S., Sartorius C.A., Horwitz K.B. Mapping the unique activation function 3 in the progesterone B-receptor upstream segment. Two LXXLL motifs and a tryptophan residue are required for activity. J. Biol. Chem. 2001, 276:39843-39851.
124. Umesono K., Evans R.M. Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell 1989, 57:1139-1146.
125. Vegeto E., Allan G.F., Schrader W.T., Tsai M.J., McDonnell D.P., O'Malley B.W. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell 1992, 69:703-713.
126. Vegeto E., Shahbaz M.M., Wen D.X., Goldman M.E., O'Malley B.W., McDonnell D.P. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol. Endocrinol. 1993, 7:1244-1255.
127. Verrijdt G., Haelens A., Schoenmakers E., Rombauts W., Claessens F. Comparative analysis of the influence of the high-mobility group box 1 protein on DNA binding and transcriptional activation by the androgen, glucocorticoid, progesterone and mineralocorticoid receptors. Biochem. J. 2002, 361:97-103.
128. Ward R.D., Weigel N.L. Steroid receptor phosphorylation: assigning function to site-specific phosphorylation. Biofactors 2009, 35:528-536.
129. Wardell S.E., Boonyaratanakornkit V., Adelman J.S., Aronheim A., Edwards D.P. Jun dimerization protein 2 functions as a progesterone receptor N-terminal domain coactivator. Mol. Cell. Biol. 2002, 22:5451-5466.
130. Wardell S.E., Kwok S.C., Sherman L., Hodges R.S., Edwards D.P. Regulation of the amino-terminal transcription activation domain of progesterone receptor by a cofactor-induced protein folding mechanism. Mol. Cell. Biol. 2005, 25:8792-8808.
131. Wardell S.E., Narayanan R., Weigel N.L., Edwards D.P. Partial agonist activity of the progesterone receptor antagonist RU486 mediated by an amino-terminal domain coactivator and phosphorylation of serine400. Mol. Endocrinol. 2010, 24:335-345.
132. Warnmark A., Wikstrom A., Wright A.P., Gustafsson J.A., Hard T. The N-terminal regions of estrogen receptor alpha and beta are unstructured in vitro and show different TBP binding properties. J. Biol. Chem. 2001, 276:45939-45944.
133. Webb P., Nguyen P., Shinsako J., Anderson C., Feng W., Nguyen M.P., Chen D., Huang S.M., Subramanian S., McKinerney E., et al. Estrogen receptor activation function 1 works by binding p160 coactivator proteins. Mol. Endocrinol. 1998, 12:1605-1618.
134. Weigel N.L., Beck C.A., Estes P.A., Prendergast P., Altmann M., Christensen K., Edwards D.P. Ligands induce conformational changes in the carboxyl-terminus of progesterone receptors which are detected by a site-directed antipeptide monoclonal antibody. Mol. Endocrinol. 1992, 6:1585-1597.
135. Williams S.P., Sigler P.B. Atomic structure of progesterone complexed with its receptor. Nature 1998, 393:392-396.
136. Wood J.R., Likhite V.S., Loven M.A., Nardulli A.M. Allosteric modulation of estrogen receptor conformation by different estrogen response elements. Mol. Endocrinol. 2001, 15:1114-1126.
137. Xu J., Nawaz Z., Tsai S.Y., Tsai M.J., O'Malley B.W. The extreme C terminus of progesterone receptor contains a transcriptional repressor domain that functions through a putative corepressor. Proc. Natl. Acad. Sci. USA 1996, 93:12195-12199.
138. Yi P., Wu R.C., Sandquist J., Wong J., Tsai S.Y., Tsai M.J., Means A.R., O'Malley B.W. Peptidyl-prolyl isomerase 1 (Pin1) serves as a coactivator of steroid receptor by regulating the activity of phosphorylated steroid receptor coactivator 3 (SRC-3/AIB1). Mol. Cell. Biol. 2005, 25:9687-9699.
139. Zhao Q., Chasse S.A., Devarakonda S., Sierk M.L., Ahvazi B., Rastinejad F. Structural basis of RXR-DNA interactions. J. Mol. Biol. 2000, 296:509-520.
140. Zhao Q., Khorasanizadeh S., Miyoshi Y., Lazar M.A., Rastinejad F. Structural elements of an orphan nuclear receptor-DNA complex. Mol. Cell 1998, 1:849-861.
141. Zilliacus J., Wright A.P., Carlstedt-Duke J., Gustafsson J.A. Structural determinants of DNA-binding specificity by steroid receptors. Mol. Endocrinol. 1995, 9:389-400.